Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
46
MRNA Quote, Financials, Valuation and Earnings
Last price:
$32.22
Seasonality move
:
-13.54%
Day range:
$31.43 - $32.17
52-week range:
$23.15 - $126.42
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.97x
P/B ratio:
1.23x
Volume:
6M
Avg. volume:
9.6M
1-year change:
-74.38%
Market cap:
$12.4B
Revenue:
$3.2B
EPS (TTM):
-$8.73
Earnings Data
Next earnings date for MRNA
Aug 01
2025
Most recent earnings per share
-$2.52
Beat by $0.59
(May 1/2025)
Consensus Estimate
-$3.11
(May 1/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MRNA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $1.2B | -- | -- | -$1.84 | -- |
| 08/01/2025 | Q2 | $114.4M | -- | -- | -$3.02 | -- |
| 05/01/2025 | Q1 | $115.3M | $107M | -$2.52 | -$3.11 | $0.59 |
| 02/14/2025 | Q4 | $941.1M | $956M | -$2.91 | -$2.73 | -$0.18 |
| 11/07/2024 | Q3 | $1.2B | $1.9B | $0.03 | -$1.94 | $1.97 |
| 08/01/2024 | Q2 | $134.9M | $221M | -$3.33 | -$3.36 | $0.03 |
| 05/02/2024 | Q1 | $125.3M | $167M | -$3.07 | -$3.55 | $0.48 |
| 02/22/2024 | Q4 | $2.5B | $2.8B | $0.55 | -$0.99 | $1.54 |
| 11/02/2023 | Q3 | -- | -- | -$9.53 | -$2.05 | -$7.48 |
| 06/30/2023 | Q2 | -- | -- | -$3.62 | -$4.12 | $0.50 |
| 03/31/2023 | Q1 | -- | -- | $0.19 | -$1.73 | $1.92 |
| 12/31/2022 | Q4 | -- | -- | $3.61 | $4.60 | -$0.99 |
| 09/30/2022 | Q3 | -- | -- | $2.53 | $3.11 | -$0.58 |
| 06/30/2022 | Q2 | -- | -- | $5.24 | $4.49 | $0.75 |
| 03/31/2022 | Q1 | -- | -- | $8.58 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | $11.29 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | $7.70 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | $6.46 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | $2.84 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.69 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.59 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.31 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.35 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.37 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.37 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.41 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.40 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.43 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.27 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.24 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.19 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$0.10 | -- | -- |
Moderna Earnings Questions
-
How Much did Moderna Generate in Revenue Last Quarter?
Moderna reported $107M worth of top line sales in its most recent quarter.
-
Did Moderna Beat Earnings Last Quarter?
Moderna announced earnings per share of -$2.52 which represents a beat of analyst forecast a -$3.11 per share.
-
Is Moderna Profitable?
Moderna reported $17M that represents $0.04 per share over the last quarter.
-
What is the Analyst Consensus for Moderna EPS Next Year?
Moderna's earnings are forecast to decrease from -$9.28 per share to -$9.03 per share next year representing a decrease of -8.28%.
-
When is Moderna's Earnings Date?
Moderna's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
